Eric Linden, DMD, MSD, MPH

595 Chestnut Ridge Road, Suite 7
Woodcliff Lake, New Jersey 07677

(201) 307-0339

Monday 8:30AM–5PM
Tuesday 9:30AM–6PM
Wednesday Closed

Thursday 8:30AM–5PM
Friday 8:30AM–4:30PM
Saturday & Sunday Closed

AAP Statement on Periodontal Treatment and Improvement in Cardiovascular Health

Month: February 2010

AAP Statement on Periodontal Treatment and Improvement in Cardiovascular Health

Research presented in a recent paper by Tonetti et al published in the New England Journal of Medicine (NEJM) suggests that intensive periodontal treatment may reverse atherosclerosis by improving elasticity of the arteries, or endothelial function. Findings from previous studies have suggested a link between periodontal disease and atherosclerosis and proposed that periodontal treatment may reduce cardiovascular risk. This study is important because it furthers the understanding of the potential relationship between periodontal disease and cardiovascular disease.

Read More »

A Healthy Smile May Promote a Healthy Heart

Each year, cardiovascular disease kills more Americans than cancer. And while most people are aware that lifestyle choices such as eating right, getting enough exercise and quitting smoking can help prevent cardiovascular disease, they may not know that by just brushing and flossing their teeth each day, they might also be avoiding this potentially lethal condition.

Read More »

Healthy Gums and a Healthy Heart: The Perio-Cardio Connection

Cardiovascular disease, the leading killer of men and women in the United States, is a major public health issue contributing to 2,400 deaths each day. Periodontal disease, a chronic inflammatory disease that destroys bone and gum tissues that support the teeth affects nearly 75 percent of Americans and is the major cause of adult tooth loss. And while the prevalence rates of these disease states seems grim, research suggests that managing one disease may reduce the risk for the other.

Read More »

Serious Oral Post-Surgical Complication Identified in Patient on Commonly Prescribed Therapy for Osteopenia

The patient of a periodontist in private practice in New Orleans, LA, developed osteonecrosis of the jaw (ONJ), a condition that can cause severe, often irreversible and debilitating damage to the jaw, following periodontal surgical therapy. Two years prior to surgery, the patient had started receiving IV bisphosphonate therapy, or bone-sparing drugs commonly used in the treatment of osteoporosis and metastatic bone cancer to help decrease associated pain and fractures, following treatment for breast carcinoma. When the patient presented to the periodontist, no reports of ONJ had been reported in the literature. This case report is published in the April issue of the Journal of Periodontology (JOP).

Read More »
Categories
Scroll to Top